My Life CagriSema 12 mg combines 6 mg Cagrilintide + 6 mg Semaglutide in a 2.6 mL pen (240 clicks). Dual-action fat loss and appetite control.
Unlock the power of dual-agonist fat loss.
👉Order My Life CagriSema 12 mg todayand take control of your metabolism for lasting transformation.
My Life – 12 mg CagriSema
(6 mg Cagrilintide + 6 mg Semaglutide | 2.6 mL pen | 240 clicks total)
Transform Your Metabolism with Dual Hormone Precision
Description
My Life CagriSema 12 mg is a dual-agonist metabolic peptide that combines two powerful hormones — Cagrilintide (an amylin analogue) and Semaglutide (a GLP-1 receptor agonist) — working synergistically to deliver breakthrough results in appetite control, fat loss, and glucose regulation.
Cagrilintide slows gastric emptying and enhances satiety, while Semaglutide boosts insulin sensitivity and suppresses hunger signals. Together, they deliver amplified and sustained weight-management effects, helping users achieve superior metabolic outcomes compared to single-pathway GLP-1 therapy.
Each 2.6 mL pen with 240 clicks provides convenient, consistent, once-weekly dosing.
General Guidelines
Administration: Inject subcutaneously (under the skin) once weekly, on the same day each week.
Injection Sites: Abdomen, thigh, or upper arm – rotate sites weekly.
Storage: Keep refrigerated at 2 – 8 °C (36 – 46 °F). Do not freeze. Protect from light.
Handling: Allow pen to reach room temperature before use. Discard after 240 clicks.
Lifestyle Support: For best results, pair My Life CagriSema with a balanced, high-protein, low-glycaemic diet and regular strength + cardiovascular training.
Suggested Dosage Progression
(240 clicks / 2.6 mL pen)
Week RangeClicks per WeekApprox. Dose (mg)Phase / NotesWeeks 1 – 45 clicks0.25 mgStart – allow body to adaptWeeks 5 – 810 clicks0.5 mgIncrease – appetite regulation beginsWeeks 9 – 1215 clicks0.75 mgIncrease – metabolic activationWeeks 13 – 1620 clicks1.0 mgIncrease – active fat-loss phaseWeek 17 +24 clicks1.2 mgMaintain – long-term stability
Each click equals approximately 0.05 mg total actives (Cagrilintide + Semaglutide). Adjust dose only under professional guidance.
Possible Side Effects
CagriSema is generally well tolerated, with mild and transient effects during titration:
Common:
Nausea or mild stomach upset
Early satiety or reduced appetite
Bloating or mild constipation
Fatigue or light dizziness
Less Common:
Heartburn or reflux
Temporary headache
Injection-site redness or tenderness
Symptoms usually subside as the body adjusts. Consult a healthcare provider if persistent.
Half-Life
Semaglutide: ~165 hours (~7 days)
Cagrilintide: ~90 hours (~4 days)
The combined pharmacology provides smooth, continuous metabolic signaling with once-weekly dosing convenience.
In Summary
My Life CagriSema 12 mg delivers a dual-hormone strategy for advanced weight-management and metabolic optimization.
With consistent use and lifestyle alignment, users can expect:
Significant and sustained fat loss
Reduced hunger and cravings
Improved insulin and glucose control
Enhanced overall metabolic health and vitality
Unlock the power of dual-agonist fat loss.
👉 Order My Life CagriSema 12 mg today and take control of your metabolism for lasting transformation.
